Antimicrobial flush solutions
AssigneeBoard of Regents, The University of Texas System
InventorIssam Raad
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorIssam Raad
Estimating the term…
The present invention provides antimicrobial solutions that comprise at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant. Also provided are methods for rapidly reducing a microbe or a virus from surfaces including surfaces of indwelling medical devices and organic surfaces such as skin and sutures, and inorganic surfaces such as hospital equipment, pipelines etc.
A device, wherein a surface of the device has been treated to render the surface more resistant to growth of microbial organisms, the treatment comprising the steps of contacting the surface of the device with an antimicrobial solution, wherein the antimicrobial solution comprises ethanol, an EDTA and either minocycline or trimethoprim, wherein the concentration of ethanol is in the range of 10% to 45% (v/v), the ethanol, EDTA and minocycline or trimethoprim being present in amounts effective to eradicate Candida parapsilosis or methicillin resistant Staphylococcus aureus embedded in a biofilm.
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Having rings with two nitrogen atoms as the only ring hetero atoms: 1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds: acyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to…:…
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
Term ended 7 Jun 2024 (estimated)
1. Field of the Invention
The present invention relates generally to the fields of medicine and microbiology. More particularly, it concerns methods of reducing microbial organisms from indwelling medical devices, medical equipment and other surfaces.
2. Description of Related Art
The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein.
FIG. 1. Ethanol in combination with M-EDTA as a flush solution used for 15 minutes or 24 hours, as indicated, tested against MRSA in biofilm.
Microorganisms that attach themselves to inert surfaces, such as medical devices including, vascular catheters, endotracheal tubes, Foley catheters, biliary stents, nephrostomy tubes, prosthetic valves, ventriculostomy or epidural catheters, or fluid pipelines, such as oil pipelines or water pipelines, produce a layer made of exopolysaccharide called microbial biofilm. These organisms embed themselves in this layer. This biofilm layer ultimately becomes the protective environment that shields these organisms on the inert surface from the antimicrobial activity of various antibiotics or antiseptics. In U.S. Pat. Nos. 5,362,754 and 5,688,516, incorporated herein by reference in their entirety, the present inventor demonstrated that a combination of one or more antimicrobial agent with one or more chelator and/or anticoagulant (such as EDTA or heparin) reduces or eradicates these antibiotic-resistant biofilm embedded microorganisms if the antimicrobial and chelator combination is allowed to dwell on the surface for at least 4 hours. However, in both clinical and environmental situations, it is typically not feasible to allow a 4 hour dwell time for the chelator and antimicrobial agent to reduce or eradicate the microbes. For example, it is not possible to interrupt the therapy of critically ill patients receiving continuous infusion therapy through a vascular catheter for 4 hours. It is also not possible to interrupt an environmental situation involving fluid pipelines for 4 hours to allow for such a prolonged dwell time of antimicrobial/chelator solution.
The present invention allows rapid reduction and/or eradication of microorganisms embedded in a biofilm in a time as short as about 15 minutes of exposure to combinations of at least one antimicrobial and at least one chelator/anticoagulant, if this combination is prepared in an alcohol. This is exemplified in one embodiment by minocycline-EDTA in an ethanol solution, which is described in detail in the application. However, one of skill in the art will recognize that one may use any antimicrobial agent, any chelator/anticoagulant and any alcohol.
In addition, the present invention provides antimicrobial solutions comprising one or more antimicrobial agents, one or more chelator/anticoagulant, and an alcohol solution. The present invention also provides methods for the rapid reduction or eradication of microorganisms embedded in a biofilm on a surface comprising contacting or exposing the surface to a flush solution of the invention. Thus, the invention provides methods for reducing or eradicating microbes from the surfaces of medical devices, including indwelling medial devices, as well as other surfaces, pipelines and the like.